SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 40 filers reported holding SESEN BIO INC in Q2 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $106,000 | -47.8% | 250,000 | 0.0% | 0.00% | -40.0% |
| Q2 2022 | $203,000 | +34.4% | 250,000 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $151,000 | -26.0% | 250,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $204,000 | -93.8% | 250,000 | -64.9% | 0.00% | -93.2% |
| Q2 2021 | $3,287,000 | +50.8% | 711,500 | -15.1% | 0.06% | +43.9% |
| Q1 2021 | $2,180,000 | +92.6% | 838,500 | 0.0% | 0.04% | +70.8% |
| Q4 2020 | $1,132,000 | -3.6% | 838,500 | 0.0% | 0.02% | -11.1% |
| Q3 2020 | $1,174,000 | +76.5% | 838,500 | -9.2% | 0.03% | +107.7% |
| Q2 2020 | $665,000 | +184.2% | 923,500 | +121.5% | 0.01% | +160.0% |
| Q1 2020 | $234,000 | -46.1% | 417,000 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $434,000 | +70.9% | 417,000 | +92.2% | 0.01% | +50.0% |
| Q3 2019 | $254,000 | -15.3% | 217,000 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $300,000 | +45.6% | 200,000 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $206,000 | +45.1% | 200,000 | +100.0% | 0.00% | +50.0% |
| Q4 2018 | $142,000 | -34.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $215,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |